Limb-sparing options for osteosarcoma-diagnosed dogs to be exploredJuly 28, 2022The Morris Animal Foundation-funded project will investigate limb-sparing options for large- and giant-breed dogs diagnosed with osteosarcoma. Ultimately, researchers hope to advance the treatment of and improve the prognosis for dogs receiving radiation treatment for this type of cancer.
SPONSORED CONTENTOne dose protects for 12 months.One ProHeart® 12 (moxidectin) injection puts compliance in your control. + Get started
Individualized care central to trial canine osteosarcoma treatment methodNovember 16, 2020Dogs diagnosed with a deadly form of bone cancer may soon have a greater chance of survival, thanks to the expansion of a clinical trial.
Vaccine appears to control canine osteosarcomaJune 25, 2020A research team at the University of Missouri (MU) College of Veterinary Medicine is exploring the use of a patient-specific, precision medicine treatment for bone cancer in dogs,
Osteosarcoma in dogs and children genetically similarJuly 26, 2019The veterinary community might soon see advancements in the treatment of canine osteosarcoma (OS).
Morris Animal Foundation receives $1 Million grant for bone cancer researchMarch 9, 2017Osteosarcoma research is about to get a big boost in funding. That’s because the Petco Foundation and the Blue Buffalo Foundation have partnered to sponsor a $1 million grant for Morris Animal Foundation to help fund the foundation’s research initiative to study the most common bone cancer in dogs.
